Skip to search formSkip to main contentSkip to account menu

dilmapimod

Known as: 8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-2-((2-hydroxy-1- (hydroxymethyl)ethyl)amino)pyrido(2,3-d)pyrimidin-7(8h)-one, Pyrido(2,3-d)pyrimidin-7(8h)-one, 8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-2-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)- 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

PyridonesPyrimidines

Narrower (1)

SB-681323

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial
The p38 mitogen‐activated protein kinase (MAPK) intracellular signaling pathway responds to a variety of extracellular stimuli… 
2013
2013
Single doses of p 38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis ( RA )
Purpose: To investigate the effects of single doses of losmapimod, dilmapimod (inhibitors of p38 MAPK) and prednisolone on… 
2012
2012
The p38 MAP kinase inhibitor dilmapimod ameliorates airway inflammation induced by ozone challenge in healthy volunteers
Background: p38 mitogen-activated (MAP) kinase may be involved in inflammatory airway diseases. We studied the effects of the… 
2012
2012
Safety and efficacy of ectoine inhalation solution in patients with inflammation and airway obstruction : The EFECT study
printing supported by . Visit Chiesi at Stand B2.10 MONDAY, SEPTEMBER 3RD 2012 Methods: The study was double-blind, randomized… 
2011
2011
Ensaio Clínico do Dilmapimod, um Inibidor da p38 MAP kinase, na Dor Neuropática Secundária à Lesão Nervosa
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)